Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Gross Margin (2022 - 2025)

Historic Gross Margin for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to 20.0%.

  • HCW Biologics' Gross Margin changed 0.0% to 20.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.0%, marking a year-over-year decrease of 124100.0%. This contributed to the annual value of 37.38% for FY2024, which is 176600.0% up from last year.
  • According to the latest figures from Q3 2025, HCW Biologics' Gross Margin is 20.0%, which was down 0.0% from 20.0% recorded in Q2 2025.
  • In the past 5 years, HCW Biologics' Gross Margin ranged from a high of 57.4% in Q1 2022 and a low of 19.08% during Q4 2023
  • Over the past 4 years, HCW Biologics' median Gross Margin value was 20.0% (recorded in 2024), while the average stood at 27.11%.
  • Its Gross Margin has fluctuated over the past 5 years, first soared by 246400bps in 2024, then plummeted by -345600bps in 2025.
  • Over the past 4 years, HCW Biologics' Gross Margin (Quarter) stood at 20.0% in 2022, then dropped by -5bps to 19.08% in 2023, then grew by 5bps to 20.0% in 2024, then dropped by 0bps to 20.0% in 2025.
  • Its Gross Margin was 20.0% in Q3 2025, compared to 20.0% in Q2 2025 and 20.0% in Q1 2025.